Aurora Cannabis Inc
Research Aurora Cannabis Inc (ACB) on Bullrun: market cap USD 284.26M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerACB
- ExchangeNASDAQ
- CountryCanada
- SectorHealthcare
- IndustryDrug Manufacturers-Specialty & Generic
- CurrencyUSD
- Market capUSD 284.26M
- Financial periodQ1 2027
- RevenueCAD 67.55M
- Net income-CAD 4.03M
- Gross margin52.7%
Valuation Snapshot
latest market cap is USD 284.26M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2026 | CAD 320.59M | -CAD 135.96M | -CAD 36.06M | 42.6% | -2.14 | CAD 64.69M | CAD 23.86M | CAD 511.83M |
| FY2025 | CAD 288.91M | CAD 1.59M | CAD 952.00K | 62.6% | 0.04 | CAD 137.92M | CAD 104.58M | CAD 567.17M |
| FY2024 | CAD 269.64M | -CAD 69.33M | -CAD 85.34M | 48.9% | -1.52 | CAD 136.10M | CAD 104.79M | CAD 559.77M |
| FY2023 | CAD 223.80M | -CAD 816.63M | n/a | 6.6% | -26.84 | CAD 234.94M | CAD 103.34M | CAD 516.45M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-09 | USD 284.26M | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 239.31M | n/a | n/a | n/a |
| 2024 | 2024-12-31 | USD 233.23M | n/a | n/a | n/a |
| 2023 | 2023-12-29 | USD 226.12M | 0.6 | n/a | n/a |
| 2022 | 2022-12-30 | USD 299.36M | n/a | n/a | n/a |
| 2021 | 2021-12-31 | USD 1.07B | n/a | n/a | n/a |
About Aurora Cannabis Inc
Aurora Cannabis Inc., together with its subsidiaries, engages in the production, distribution, and sale of cannabis products in Canada and internationally. The company offers pharmaceutical-grade cannabis products; and medical and consumer cannabis products.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Aurora Cannabis Inc's market cap?
Aurora Cannabis Inc's market capitalization is USD 284.26M.
What does Aurora Cannabis Inc do?
Aurora Cannabis Inc., together with its subsidiaries, engages in the production, distribution, and sale of cannabis products in Canada and internationally. The company offers pharmaceutical-grade cannabis products; and medical and consumer cannabis products. It also provides harvested cannabis, trim, cannabis oils, capsules, edibles, vaporizers, dried and fresh cannabis, cannabis plants, cannabis seeds, edible cannabis, cannabis extracts, flowers, vapes / inhalable extracts, edibles / pastilles, concentrates, and cannabis topicals; and patient counseling and outreach services.